Cover
Vol. 12 No. 1 (2022)

Published: June 30, 2022

Pages: 16-25

Research Article

Correlation of serum and follicular fluid EMMPRIN levels at day of ova pick up and embryo transfer to endometrial thickness and its effect on ICSI outcomes in fresh cycles.

Methaq Hassan Hashim 1 Amal Abdulwahid Mohammed Ali Ibrahim Rahim 2
1High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq.
2Al-Ameed University, College of Medicine; Al-Kafeel Specialized Hospital, IVF Center; Karbala
History
  • Received: April 30, 2022
  • Accepted: May 30, 2022
  • Available Online: June 8, 2022
DOI

https://doi.org/10.28969/IJEIR.v12.i1.r2.22

Abstract

EMMPRIN (Basigin) is a potent inducer of matrix metalloproteinases (MMPs). Expression of EMMPRIN in the uterus has a very important role in implantation of embryo, this study was conducted to evaluate the relationship of pregnancy rates with EMMPRIN levels in follicular fluid and serum of intracytoplasmic sperm injection patients. The study was cross sectional study analyzed the serum and follicular fluid samples of 58 patients undergo ICSI procedure. The serum and follicular fluid samples were collected from infertile women aged 20 to 42 years. However, the levels of EMMPRIN were measured in the serum and follicular fluid samples and these samples were obtained during oocytes retrieval and another serum samples were collected at the day of embryo transfer. All women have ovarian stimulation with recombinant follicle stimulating hormone (FSH) at the second or third day of the cycle. Result: The pregnancy rate was 27.6 %. The present study showed that EMMPRIN in serum and follicular fluid at day of ova pickup and its level at embryo transfer day, are significantly low in pregnant women (p < 0.05) compared to non-pregnant women. The statistical analysis showed no significant correlation between serum and follicular fluid EMMPRIN with endometrial thickness (p > 0.05). EMMPRIN level can be used as a promising parameter for the prediction of pregnancy rate in ICSI cycles.

Keywords

References

  1. Esteves, S. C., Roque, M., Bedoschi, G., Haahr, T., & Humaidan, P. (2018). Intracytoplasmic sperm injection for male infertility and consequences for offspring. Nature Reviews Urology, 15 (9), 535-562. https://doi.org/10.1038/s41585-018-0051-8
  2. Governini, L., Luongo, F. P., Haxhiu, A., Piomboni, P., & Luddi, A. (2021). Main actors behind the endometrial receptivity and successful implantation. Tissue and Cell, 73, 101656. https://doi.org/10.1016/j.tice.2021.101656
  3. Fournier, S. B., D’Errico, J. N., & Stapleton, P. A. (2021). Uterine Vascular Control Preconception and During Pregnancy. Comprehensive Physiology, 11 (3), 1871. https://doi.org/10.1002/cphy.c190015
  4. Scolari, S. C., Pugliesi, G., Strefezzi, R. D. F., Andrade, S. C., Coutinho, L. L., & Binelli, M. (2017). Dynamic remodeling of the endometrial extracellular matrix regulates embryo receptivity in cattle. Reproduction, 153 (1), 49-61. https://doi.org/10.1292/jvms.64.207
  5. Chen L, Bi J, Nakai M, Bunick D, Couse JF, Korach KS & Nowak RA 2010 Expression of basigin in reproductive tissues of estrogen receptor-?? or -?? Null mice. Reproduction 1057–1066. https://doi.org/10.1530/REP-10-0069
  6. Benkhalifa, M., Zayani, Y., Bach, V., Copin, H., Feki, M., Benkhalifa, M., & Allal-Elasmi, M. (2018). Does the dysregulation of matrix metalloproteinases contribute to recurrent implantation failure? Expert Review of Proteomics, 15 (4), 311- 323. https://doi.org/10.1080/14789450.2018.146 4915
  7. Yoshii, N., Hamatani, T., Inagaki, N., Hosaka, T., Inoue, O., Yamada, M., Machiya, R., Yoshimura, Y. and Odawara, Y., 2013. Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity. Reproductive Biology and Endocrinology, 11 (1), pp.1-10. https://doi.org/10.1186/1477-7827-11-37
  8. Dang, Y., Li, W., Tran, V. and Khalil, R.A., 2013. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone. Biochemical pharmacology, 86 (6), pp.734- 747. https://doi.org/10.1016/j.bcp.2013.06.030
  9. Li, K., & Nowak, R. A. (2020). The role of basigin in reproduction. Reproduction, 159 (2), R97-R109. https://doi.org/10.1530/REP-19-0268
  10. Griesinger, G., Blockeel, C., Kahler, E., Pexman-Fieth, C., Olofsson, J. I., Driessen, S., & Tournaye, H. (2020). Dydrogesterone As an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PloS one, 15 (11), e0241044. https://doi.org/10.1371/journal.pone.02410 44
  11. Davis, J. S., & LaVoie, H. A. (2019). Molecular regulation of progesterone production in the corpus luteum. In The ovary (pp. 237-253). Academic Press. https://doi.org/10.1016/B978-0-12-813209- 8.00015-7
  12. Alzaidi, Z., Yildiz, Ş.M., Saatçi, Ç. et al. The effect of cytokine leukemia- inhibitory factor (LIF) and interleukin-11 (IL-11) gene expression on the primary infertility related to polycystic ovary syndrome, Tubal factor, and Unexplained infertility in Turkish women. Egypt J Med Hum Genet 22, 85 (2021). https://doi.org/10.1186/s43042-021-00201- 9